Skip to content
10-K

Annual Report

BIOCANCELL THERAPEUTICS INC.

0001178913-12-000905

← back to feed
Filed
Mar 30, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 28, 2012 39.39M sh
Stock Repurchased FY 2011 · Dec 31, 2011 $4.95M
Capex FY 2011 · Dec 31, 2011 $14K
Capex FY 2011 · Dec 31, 2011 $237K
Capex FY 2011 · Dec 31, 2010 $11K
Operating Cash Flow FY 2011 · Dec 31, 2011 −$5.1M
Operating Cash Flow FY 2011 · Dec 31, 2011 −$23.16M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$3.05M
Cash And Equivalents FY 2011 · Dec 31, 2011 $240K
Cash And Equivalents FY 2011 · Dec 31, 2010 $3.49M
Cash And Equivalents FY 2011 · Dec 31, 2009 $624K
Stockholders Equity FY 2011 · Dec 31, 2011 −$3.5M
Stockholders Equity FY 2011 · Dec 31, 2010 $2.1M
Stockholders Equity FY 2011 · Dec 31, 2009 −$3.37M
Stockholders Equity FY 2011 · Dec 31, 2008 $1.95M
Stockholders Equity FY 2011 · Dec 31, 2007 $2.53M
Stockholders Equity FY 2011 · Dec 31, 2006 $6.02M
Stockholders Equity FY 2011 · Dec 31, 2005 $1.43M
Stockholders Equity FY 2011 · Dec 31, 2004 −$220K
Current Liabilities FY 2011 · Dec 31, 2011 $3.99M
Current Liabilities FY 2011 · Dec 31, 2010 $1.13M
Current Assets FY 2011 · Dec 31, 2011 $808K
Current Assets FY 2011 · Dec 31, 2010 $5.7M
Total Assets FY 2011 · Dec 31, 2011 $1.4M
Total Assets FY 2011 · Dec 31, 2010 $6.11M
Sga Expense FY 2011 · Dec 31, 2011 $2.13M
Sga Expense FY 2011 · Dec 31, 2011 $10.38M
Sga Expense FY 2011 · Dec 31, 2010 $1.96M
Rd Expense FY 2011 · Dec 31, 2011 $3.93M
Rd Expense FY 2011 · Dec 31, 2011 $17.41M
Rd Expense FY 2011 · Dec 31, 2010 $2.21M
Net Income FY 2011 · Dec 31, 2011 −$6.02M
Net Income FY 2011 · Dec 31, 2011 −$25.32M
Net Income FY 2011 · Dec 31, 2010 −$2.18M
Net Income FY 2011 · Dec 31, 2009 −$6.8M
Net Income FY 2011 · Dec 31, 2008 −$2.94M
Net Income FY 2011 · Dec 31, 2007 −$3.94M
Net Income FY 2011 · Dec 31, 2006 −$2.32M
Net Income FY 2011 · Dec 31, 2005 −$834K
Net Income FY 2011 · Dec 31, 2004 −$300K
Operating Income FY 2011 · Dec 31, 2011 −$5.65M
Operating Income FY 2011 · Dec 31, 2011 −$24.96M
Operating Income FY 2011 · Dec 31, 2010 −$3.77M
Short Term Investments FY 2011 · Dec 31, 2010 $1.99M